17 completed, 5 unknown, 2 recruiting, 2 terminated. 26 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 26 | Completed 17, Unknown 5, Recruiting 2, Terminated 2 |
| Phase 2 | 6 | Completed 4, Unknown 2 |
Follow Placebo capsules: new trials by email Literature Review of Placebo capsules trials Research Report on Placebo capsules
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fecal Transplantation to Eradicate Colonizing Emergent Superbugs Fecal Microbiota Transplantation (FMT) capsules, Placebo capsules - Enterobacteriaceae Infections, Fecal Microbiota Transplantation | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 214 | 2024-01-11 | 2025-05-25 |
| Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury Placebo diet, Anti-inflammatory diet, Nabilone Capsules - Spinal Cord Injuries, Neuropathic Pain | Phase 3 | Completed | Eldon Loh, MD | 14 | 2023-03-01 | 2025-07-22 |
| Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis Pirfenidone Capsules, placebo capsules - Pneumoconiosis | Phase 3 | Recruiting | Beijing Continent Pharmaceutical Co, Ltd. | 272 | 2022-06-07 | 2025-11-24 |
| Assessment of Efficacy of KAN-JANG® in Mild COVID-19 Kan Jang capsules, Placebo capsules - Covid19 | Phase 2 / Phase 3 | Unknown | Swedish Herbal Institute AB | 140 | 2021-05-26 | 2021-09-22 |
| The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder FMT oral Capsules, Placebo Capsules - Depression, Treatment Resistant Depression | Phase 2 / Phase 3 | Unknown | University of Calgary | 80 | 2021-03-04 | 2023-11-28 |
| Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy Dutasteride Capsules, Placebo Capsules - Alcohol Use Disorder | Phase 2 / Phase 3 | Completed | UConn Health | 180 | 2019-10-15 | 2025-05-09 |
| A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients Fluzoparib capsules, Placebo capsules - Ovarian Cancer | Phase 3 | Completed | Jiangsu HengRui Medicine Co., Ltd. | 252 | 2019-04-30 | 2025-07-03 |
| Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery Pregabalin, Placebos - Persistent Postoperative Pain | Phase 3 | Terminated | Benno Rehberg-Klug | 126 | 2018-01-09 | 2026-06-17 |
| L-carnitine for Fatigue in COPD L-carnitine 1000 mg twice daily, Weekly health coaching calls, Placebo capsules - Copd, Fatigue | Phase 2 / Phase 3 | Completed | Mayo Clinic | 33 | 2017-01-01 | 2019-01-23 |
| Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST Placebo capsules, Bardoxolone methyl capsules - Connective Tissue Disease-Associated Pulmonary Arterial Hypertension | Phase 3 | Terminated | Biogen | 202 | 2016-10-04 | 2025-06-04 |
| Stroke and Tocotrienol: Unique Role in Neuroprotection Tocotrienol, Placebo capsules - Ischemic Stroke | Phase 3 | Unknown | Seberang Jaya Clinical Research Centre | 150 | 2015-07-01 | 2018-02-13 |
| Evaluating the Role of Chloroquine for Malaria Elimination Chloroquine, Placebo - Malaria | Phase 2 / Phase 3 | Completed | Centro de Investigacao em Saude de Manhica | 75 | 2015-01-01 | 2018-02-07 |
| A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% Androxal 12.5 mg/25 mg, Placebo Capsules, AndroGel 1.62% - Secondary Hypogonadism | Phase 3 | Completed | Repros Therapeutics Inc. | 120 | 2014-01-01 | 2014-10-01 |
| A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% Androxal 12.5 mg or 25 mg, AndroGel 1.62%, Placebo Capsules - Secondary Hypogonadism | Phase 3 | Completed | Repros Therapeutics Inc. | 120 | 2014-01-01 | 2014-10-01 |
| Study of Meloxicam Capsules to Treat Osteoarthritis Pain Meloxicam Test Capsules, Placebo Capsules - Osteoarthritis | Phase 3 | Completed | Iroko Pharmaceuticals, LLC | 403 | 2013-02-01 | 2015-03-11 |
| Study for Effectiveness Evaluation of Panax Ginseng, Vitamins and Minerals (Natugerin®) in Improvement of Stress and Fatigue NatusGerin, Placebo capsules - Stress, Fatigue | Phase 3 | Unknown | Azidus Brasil | 300 | 2011-09-01 | 2010-10-25 |
| Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) Brisdelle (paroxetine mesylate), Placebo capsules - Postmenopausal Symptoms | Phase 3 | Completed | Noven Therapeutics | 614 | 2011-05-01 | 2015-10-15 |
| Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD Methylphenidate Hydrochloride Extended Release Capsules, Placebo - Attention Deficit Hyperactivity Disorder, ADHD | Phase 3 | Completed | Rhodes Pharmaceuticals, L.P. | 230 | 2010-11-01 | 2023-02-22 |
| Safety and Efficacy Study of Lithium for the Treatment of Pediatric Mania. Lithium Carbonate, Placebo - Bipolar Disorder | Phase 2 / Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 81 | 2010-06-01 | 2013-10-09 |
| the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis eN-Lac®, Placebo - Perennial Allergic Rhinitis, Probiotics | Phase 3 | Completed | GenMont Biotech Incorporation | 236 | 2010-05-01 | 2015-09-02 |
Showing 20 of 26. Sign in to see all of them.
Arthritis, Rheumatoid (2) · Fatigue (2) · Hypogonadism (2) · Pulmonary Disease, Chronic Obstructive (2) · Alcoholism (1) · Attention Deficit Disorder with Hyperactivity (1) · Bipolar Disorder (1) · COVID-19 (1) · Depression (1) · Depressive Disorder, Major (1) · Depressive Disorder, Treatment-Resistant (1) · Diabetes Mellitus (1) · Enterobacteriaceae Infections (1) · Hot Flashes (1) · Hypertension, Pulmonary (1)
Centocor, Inc. (2) · Noven Therapeutics (2) · Repros Therapeutics Inc. (2) · Assistance Publique - Hôpitaux de Paris (1) · Azidus Brasil (1) · Beijing Continent Pharmaceutical Co, Ltd. (1) · Benno Rehberg-Klug (1) · Biogen (1) · Centro de Investigacao em Saude de Manhica (1) · Corbridge Group Philippines, Inc. (1) · Eldon Loh, MD (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · GenMont Biotech Incorporation (1) · Iroko Pharmaceuticals, LLC (1) · Jiangsu HengRui Medicine Co., Ltd. (1)
United States (12) · Canada (5) · Taiwan (4) · Argentina (3) · Australia (3) · Philippines (3) · South Korea (3) · Belgium (2) · Chile (2) · China (2) · Germany (2) · Hungary (2) · India (2) · Japan (2) · Malaysia (2)
Arthur Waldbaum, MD (2) · Cynthia Strout, MD (2) · David J Portman, MD (2) · Derrick R Havin, MD (2) · Donna DeSantis, MD (2) · Eric Ross, MD (2) · Marvin Kalafer, MD (2) · Mildred Farmer, MD (2) · Robin Kroll, MD (2) · Sandra Hurtado, MD (2) · Stephen Swanson, MD (2) · Tyrone Malloy, MD (2) · Alan Kivitz, MD (1) · Alfred Poindexter, MD (1)
PMID 24045678, PMID 24552977, PMID 25137243, PMID 27803138, PMID 21083889, PMID 22127693, PMID 22505702, PMID 23040786, PMID 23678153, PMID 23861303, PMID 24757132, PMID 25005327, PMID 25877989, PMID 26459650, PMID 26503347, PMID 27432355, PMID 27696724, PMID 28465550, PMID 28606966, PMID 29546346, PMID 30412238, PMID 30738555, PMID 35404684, PMID 37916745
2004 (1), 2019 (1), P50AA027055 (1)